Biostatistics: the hidden path to life science innovation

Author

Peters, Lois ; Burke, Richard ; Mehta, Shreefal

Author_Institution

Lally Sch. of Manage. & Technol., Rensselaer Polytech. Inst., Troy, NY, USA

Volume

1

fYear

2001

fDate

2001

Abstract

Summary form only given. This exploratory paper investigates the infrastructure for life-science-based new product development. The practice of biostatistics has long been seen as a crucial element of the regulatory process for approving the release of new drugs and medical devices, but we hypothesize that it serves a larger role in the new product development process in pharmaceutical and biotechnology firms. We focus on the role of biostatistical-related disciplines to help us understand how the management of these technologies and practices feature in building firm competitiveness, by employing multiple case studies and analysis of secondary data

Keywords

biotechnology; pharmaceutical industry; product development; research and development management; statistical analysis; biostatistical-related disciplines; biostatistics; biotechnology firms; firm competitiveness; life science innovation; medical devices release; multiple case studies employment; new drugs release; new product development; pharmaceutical firms; regulatory process; technology management; Biotechnology; Data analysis; Drugs; Paper technology; Pharmaceutical technology; Product development; Protocols; Statistics; Technological innovation; Technology management;

fLanguage

English

Publisher

ieee

Conference_Titel

Management of Engineering and Technology, 2001. PICMET '01. Portland International Conference on

Conference_Location

Portland, OR

Print_ISBN

1-890843-06-7

Type

conf

DOI

10.1109/PICMET.2001.952243

Filename

952243